The European Union drug regulator has recommended authorizing the Pfizer/Bio NTech Covid 19 vaccine for use , paving the way for the first phase of the bloc 's mass vaccination program to begin later this week . 
In a closed door meeting in Amsterdam on Monday , the European Medicines Agency ( EMA ) granted the Pfizer/Bio NTech vaccine a conditional marketing authorization , green lighting the drug for distribution . 
Before the 27 nation bloc can begin its rollout , the European Commission must give its final approval , which European Commission President Ursula von der Leyen would likely happen later on Monday . 
The EMA 's head of communications Marie Agnes Heine called the move a " significant milestone in the fight against the pandemic " during a virtual press briefing with reporters . 
The UK and the US granted emergency use authorization of the Pfizer/Bio NTech vaccine earlier this month , and hundreds of thousands in those countries have since received their first shots . 
Read more about the vaccine approval process in Europe here . 
